EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of Ketamine vs. Midazolam in Adolescent Treatment Resistant Depression

Andrea Macejova, Veronika Kovacova, Ingrid Tonhajzerova iD, Zuzana Visnovcova, Nikola Ferencova iD, Zuzana Mlyncekova iD, Tomas Kukucka, Igor Ondrejka iD

Pharmaceuticals · 04.12.2024 · 17 (12) · 1627

DOI: 10.3390/ph17121627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 04.12.2024. Verfasst von Andrea Macejova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Psychiatry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital Martin, Kollarova 2, 03601 Mart…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovak Scientific Grant Agency under a VEGA grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adolescent treatment resistant depression (TRD) is increasing in recent years. While ketamine showed rapid antidepressant effects in adult TRD studies, research on its effectiveness in adolescents is limited.

Methods

This study examines the effects of intravenous ketamine vs. midazolam on depressive and anxiety symptomatology assessed by the Montgomery–Åsberg Depression Rating Scale (MADRS), Hamilton Anxiety Rating Scale (HAM-A), and Children’s Depression Inventory (CDI) at two time points—2 h after initial infusion (T0+2h) and 24 h after the end of the treatment (Te+24h) in a sample of 55 adolescent TRD females (27 receiving ketamine, 28 midazolam).

Results

At T0+2h, within-group comparisons revealed a significant reduction in MADRS and HAM-A scores compared to baseline in the ketamine and midazolam groups. At Te+24h, both groups demonstrated similar significant reductions in MADRS, HAM-A, and CDI scores compared to baseline. The MADRS assessment in the ketamine group showed 33% and 59% responders, and in the midazolam group, 14% and 46% responders at T0+2h and Te+24h, respectively. HAM-A evaluation in the ketamine group revealed 33% and 56% responders, and in the midazolam group, 11% and 39% responders at T0+2h and at Te+24h, respectively. CDI rating discovered 11% and 44% responders in the ketamine group and 4% and 21% responders in the midazolam group at T0+2h and Te+24h, respectively. Moreover, inner tension significantly decreased in ketamine compared to the midazolam group at Te+24h.

Conclusions

Ketamine showed a reduction in depressive and anxiety symptoms during a short-term period with particular efficacy in alleviating inner tension over midazolam, suggesting its potential advantages in specific symptom relief in rarely studied adolescent TRD.

Schlagwörter

Stichwörter der Autor:innen

adolescent ageketaminemidazolamnovel antidepressantstreatment-resistant depression

Autor:innen und Institutionen

  • Clinic of Psychiatry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital Martin, Kollarova 2, 03601 Martin, Slovakia.
  • Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 03601 Martin, Slovakia.
  • Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4D, 03601 Martin, Slovakia.

ORCID-Profile: Ingrid Tonhajzerova, Nikola Ferencova, Zuzana Mlyncekova, Igor Ondrejka

Förderung

  • Slovak Scientific Grant Agency under a VEGA grant

Zitieren

APA

Macejova, A., Kovacova, V., Tonhajzerova, I., Visnovcova, Z., Ferencova, N., Mlyncekova, Z., Kukucka, T., & Ondrejka, I. (2024). Effects of Ketamine vs. Midazolam in Adolescent Treatment Resistant Depression. Pharmaceuticals, 17(12), 1627. https://doi.org/10.3390/ph17121627

Vancouver

Macejova A, Kovacova V, Tonhajzerova I, Visnovcova Z, Ferencova N, Mlyncekova Z, et al. Effects of Ketamine vs. Midazolam in Adolescent Treatment Resistant Depression. Pharmaceuticals. 2024;17(12):1627. doi:10.3390/ph17121627

BibTeX
@article{Macejova2024,
  author = {Macejova, Andrea and Kovacova, Veronika and Tonhajzerova, Ingrid and Visnovcova, Zuzana and Ferencova, Nikola and Mlyncekova, Zuzana and Kukucka, Tomas and Ondrejka, Igor},
  title = {Effects of Ketamine vs. Midazolam in Adolescent Treatment Resistant Depression},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {12},
  pages = {1627},
  doi = {10.3390/ph17121627}
}
Kostenlos starten →